Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Budget negotiations: cut industry subsidies, not public interest research!

To: Members of the European Parliament, Member States of the European Union

Dear Member of the European Parliament, dear Madam, dear Sir,

You are now involved in the final negotiations around the EU's budget for 2014-2020. The position reached by the European Council's February 8th meeting concludes that a significant cut in research funding is being considered. According to European Commission estimates, this would translate into a €10 billion cut in Horizon 2020, out of an original €80 billion budget1.

Civil society organisations have been denouncing Horizon 2020's excessive corporate bias since the very first Green paper published by the Commission in 20112, but big business' lobbying prevailed. As it stands, the project is divided into three pillars, with the entire second pillar - more than €20 billion – allocated to a program called “Industrial leadership”, for activities with a “business-driven agenda”3.

Past experience with similar business-driven EU Research programs shows that despite promises that the priority for these funds will be SMEs, for new research projects, they have mainly been captured by large multinational corporations, to finance research activities that were already planned4. This means that these much-needed research funds have been transformed into industry subsidies, with little added value in terms of research results and questionable legitimacy when these same companies slash their workforce while still paying out dividends and bonuses. One example is the Joint Technology Initiative “Clean Sky”, a public-private partnership between the European Commission and industry, in which €400 million of taxpayers' money is directly transferred to the largest companies participating (such as EADS, Thales, Dassault, Finmeccanica, Rolls-Royce...)5.

Dedicating even more money to a failed policy is not an acceptable use of scarce public funds. We request that the “Industrial Leadership” program is the sole recipient of budget cuts, and that more money is made available for crucial research needs in areas such as food safety, preventative health policy, fundamental public research, ecology-focussed agriculture or renewable energies. Public research funding should go to public interest projects.



Signatories

ARC 2020
ASEED Europe
BUKO Pharma-Kampagne
Corporate Europe Observatory
Committe for Independent Research and Information on Genetic Engineering (CRIIGEN)
Earth Open Source
European Coordination Via Campesina (ECVC)
European Public Services Union (EPSU)
European Network of Scientists for Social and Environmental Responsibility (ENSSER)
Fondation Sciences Citoyennes
Fondazione Italiana per la Ricerca in Agricoltura Biologica e Biodinamica (FIRAB)
GMWatch
Health and Environment Alliance (HEAL)
International Federation of Organic Agriculture Movements (IFOAM) EU Group
Living Knowledge Network
Naturschutzbund Deutschland e.V. (NABU)
Pesticides Action Europe (PAN)
Testbiotech
Wissenschaftsladen Wien - Science Shop Vienna

 

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate